AiCure

Drug Sponsors

Paratek Pharmaceuticals completes merger with Transcept Pharmaceuticals

Friday, October 31, 2014 02:04 PM

Boston-based Paratek Pharmaceuticals and Transcept Pharmaceuticals, based in California, have completed their merger. Transcept changed its name to Paratek Pharmaceuticals.

More... »


ReproCELL acquires Reinnervate and BioServe

Friday, October 31, 2014 01:54 PM

ReproCELL, a venture company in the iPS cell business originating from the University of Tokyo and Kyoto University, has acquired U.K.-based Reinnervate, a spin-out company from Durham University, a center of excellence in cell biology research, and BioServe Biotechnologies, based in Maryland, to accelerate its iPS cell business.

More... »

CenterWatch

Abbott acquires medical device company Topera

Thursday, October 30, 2014 12:19 PM

Abbott has entered into an agreement to purchase Topera, a Menlo Park, Calif.-based, private, venture-backed medical device company focused on developing innovative electrophysiology technologies to improve the diagnosis and treatment of atrial fibrillation, one of the most common heart rhythm disorders in the world. Through this acquisition, Abbott enters the catheter-based electrophysiology market, an approximately $3 billion global market that has been growing annually at double-digit rates.

More... »

Sanofi board ousts CEO Viehbacher

Thursday, October 30, 2014 08:46 AM

By Ronald Rosenberg
CenterWatch Staff Writer

Paris-based biopharmaceutical company Sanofi ousted CEO Chris Viehbacher Wednesday, just two days after reporting disappointing quarterly earnings.

More... »

Wright Medical Group, Tornier to merge

Wednesday, October 29, 2014 01:29 PM

Wright Medical Group, a specialty orthopedic company that provides extremity and biologic solutions, and Tornier, a global medical device company, have entered a definitive merger agreement under which Wright and Tornier will combine in an all-stock transaction with a combined equity value of approximately $3.3 billion.

More... »

Amgen outlines strategy, will cut up to 4,000 jobs

Wednesday, October 29, 2014 01:28 PM

Amgen has outlined the company's strategy, growth objectives and capital allocation plans, and provided financial guidance for 2015. In addition to the approximately 2,900 positions already set to be eliminated by the end of 2015, an additional 600 to 1,100 jobs will be cut.

More... »

SRI International opens clinical trial unit in Michigan

Monday, October 27, 2014 01:04 PM

SRI Biosciences, a division of SRI International, a California-based independent nonprofit research institute, has completed construction of an early-phase clinical trial facility in Plymouth, Mich. The 9,400-square-foot unit, located in the Michigan Life Science Innovation Center, now is open and fully equipped for early-stage human research studies of new medicines and medical devices. 

More... »

Report: 10 men for every woman present in biotech boardrooms

Monday, October 27, 2014 12:57 PM

The biotechnology sector is considerably under represented by female executives and board directors, according to a new report by Liftstream, a U.K.-based company providing executive recruitment services to the biotechnology sector. The gender diversity report, Diversifying the Outlook—The X&Y of Biotechnology Leadership, is a detailed analysis of women leaders in European and U.S. biotech companies.

More... »

Lilly, Zymeworks expand collaboration agreement

Friday, October 24, 2014 01:10 PM

Eli Lilly and Zymeworks, a Vancouver-based, privately held biotherapeutics company, are expanding an existing licensing and collaboration agreement. Originally announced in January, the global strategic collaboration is focused on the development of an undisclosed number of novel bi-specific antibody therapeutics using Zymeworks' proprietary Azymetric platform.

More... »

Celgene collaborates with Sutro Biopharma, inks option to acquire

Friday, October 24, 2014 01:09 PM

Sutro Biopharma, located in South San Francisco, has entered into a strategic collaboration and option agreement with Celgene to discover and develop multispecific antibodies and antibody drug conjugates (ADCs). This new agreement follows the December 2012 collaboration between the two companies and focuses on the field of immuno-oncology, while further broadening the Sutro platform for discovery, development and manufacture of best-in-class biotherapeutics.

More... »

Link to survey
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs